Table 2.
Patients’ data and summary of usage of BMSCs
Used for | Date | BSI ID | DIN | Age | Gender | Classification | Tryptase (ng/mL) | Mast cell aggregates | % invovement | |
---|---|---|---|---|---|---|---|---|---|---|
1 | BRDU proliferation assay | 3/31/10 | 56 | M | Smoldering | 341 | yes | 50 | ||
2 | clotted | 7/28/10 | 40 | M | Indolent | 20 | yes | 10 | ||
3 | clotted | 6/9/11 | 65 | M | Indolent | 74 | yes | 5 | ||
4 | clotted | 5/12/11 | 51 | F | Indolent | 188 | yes | 30 | ||
5 | did not grow | 9/8/10 | 49 | F | Indolent | 35 | yes | 5 | ||
6 | did not grow | 11/3/10 | 44 | M | Indolent | 105 | yes | 30 | ||
7 | colonies for morphology | 4/14/10 | 42 | F | Smoldering | 150 | yes | 40 | ||
8 | colonies for morphology | 11/15/07 | 48 | F | Indolent | 287 | yes | 40 | ||
9 | FACS analysis, repopulation assay | 5/5/10 | 63 | F | Indolent | 52 | yes | 15 | ||
10 | repopulation assay | 6/9/10 | 58 | F | indolent | 29 | yes | 10 | ||
11 | repopulation assay | 4/21/10 | 67 | M | Indolent | 123 | yes | 40 | ||
12 | frozen, ossicle | 7/1/10 | 37 | F | Indolent | 46 | yes | 30 | ||
13 | frozen, ossicle | 7/7/10 | 66 | F | No mastocytosis | 17 | no | 0 | ||
14 | frozen, ossicle | 8/18/10 | 51 | F | Indolent | 68 | yes | 30 | ||
15 | frozen, ossicle | 7/14/10 | 61 | F | Smoldering | 319 | yes | 30 | ||
16 | gene array | 1/20/11 | MC000299 | 11FC00007 | 23 | F | 2 minor criteria | 10 | no | <5 |
17 | gene array | 2/17/11 | MC000304 | 11FC00024 | 41 | F | Indolent | 13 | yes | 20 |
18 | gene array | 3/30/11 | MC000328 | 11FC00048 | 47 | F | Indolent | 25 | yes | 15 |
19 | gene array | 3/2/11 | MC000306 | 11FC00031 | 57 | M | Indolent | 68 | yes | 10 |
20 | gene array | 3/31/11 | MC000329 | 11FC00049 | 40 | F | Indolent | 79 | yes | 15 |
21 | gene array | 1/5/11 | 11FC00001 | 24 | F | Indolent | 80 | yes | 15 | |
22 | gene array | 1/13/11 | 11FC00003 | 27 | F | Indolent | 100 | yes | 50 | |
23 | gene array | 2/9/11 | MC000303 | 11FC00020 | 55 | F | Smoldering | 119 | yes | 30 |
24 | gene array | 3/10/11 | MC000318 | 11FC00038 | 58 | F | Aggressive | 120 | yes | 40 |
25 | gene array | 2/2/11 | 11FC00015 | 48 | F | Smoldering | 166 | yes | 50 | |
26 | gene array | 3/3/11 | MC000307 | 11FC00032 | 71 | F | indolent | 173 | yes | 30 |
27 | normal and abnormal colonies, adipo and ostegenic assay | 8/26/10 | 45 | F | 2 minor criteria | 6 | no | scattered mast cells | ||
28 | normal and abnormal colonies, adipo and ostegenic assay | 9/2/10 | 43 | F | Indolent | 17 | yes | 20 | ||
29 | normal and abnormal colonies, adipo and ostegenic assay | 9/9/10 | 52 | M | Indolent | 24 | yes | 15 | ||
30 | normal and abnormal colonies, adipo and ostegenic assay | 11/10/10 | 36 | F | Indolent | 35 | yes | 5 | ||
31 | normal and abnormal colonies, adipo and ostegenic assay | 10/27/10 | 32 | F | Smoldering | 215 | yes | 35 | ||
32 | normal and abnormal colonies, adipo and ostegenic assay | 11/18/09 | 48 | M | Indolent | 65 | yes | 5 |
>25% Spindle shaped | CD2 | CD25 | KIT mutation | Cytopenia | Hepatosplenomegaly | Osteopenia/Osteoporosis | Cytoreductive Treatment | |
---|---|---|---|---|---|---|---|---|
1 | yes | + | + | KIT D816V | no | yes | yes | |
2 | yes | + | + | KIT D816V | no | no | no | |
3 | yes | + | + | KIT D816V | thrombocytopenia | no | no | |
4 | yes | + | + | KIT D816V | no | no | osteoporosis | colon CA s/p R hemicolectomy with adjuvant chemotherapy |
5 | yes | + | + | KIT D816V | no | splenomegaly | yes | |
6 | yes | + | + | KIT D816V | no | no | osteoporosis | |
7 | yes | + | + | KIT D816V | no | yes | no | |
8 | yes | + | + | KIT D816V | eosinophilia | splenomegaly/hepatomegaly | osteoporosis | |
9 | yes | + | + | KIT D816V | no | hepatomegaly | yes | |
10 | yes | + | + | KIT D816V | no | no | yes | |
11 | yes | + | + | KIT D816V | no | no | no | |
12 | yes | + | + | KIT D816V | no | no | no | |
13 | no | − | − | - | no | no | no | |
14 | yes | + | + | KIT D816V | no | no | no | |
15 | yes | + | + | KIT D816V | thrombocytosis | no | yes | |
16 | yes | − | + | - | no | no | osteopenia | |
17 | yes | + | + | - | no | no | no | |
18 | yes | + | + | KIT D816V | no | no | no | imatinib |
19 | yes | + | + | KIT D816V | no | no | no | |
20 | yes | + | + | KIT D816V | no | no | no | |
21 | yes | + | + | KIT D816V | no | no | osteopenia | |
22 | no | − | − | KIT K5091 germline | no | no | no | |
23 | yes | + | + | KIT D816V | leukopenia | splenomegaly/hepatomegaly | no | |
24 | yes | + | + | KIT D816V/KRAS G12D | thrombocytopenia | splenomegaly | no | |
25 | yes | + | + | KIT D816V | no | hepatomegaly | no | IFN alpha |
26 | yes | + | + | KIT D816V | no | no | no | |
27 | yes | − | + | - | no | no | no | |
28 | yes | − | − | KIT D816V | no | no | no | |
29 | yes | + | + | KIT D816V | no | no | yes | |
30 | yes | + | + | KIT D816V | no | no | no | |
31 | yes | + | + | KIT D816V | no | no | no | |
32 | yes | + | + | KIT D816V | no | no | yes |